![](https://img.einpresswire.com/small/708478/lad-and-sites-2.png)
KD Pharma Group to acquire dsm-firmenich’s marine lipids business in exchange for a minority stake in the company
The transaction expands KD Pharma Group‘s lipids CDMO business and includes the MEG-3® fish oil omega-3 product portfolio and two associated production sites BIOGGO, EUROPE, SWITZERLAND, July 18, 2024 /EINPresswire.com/ -- The KD Pharma Group, a leading …